Hradyk Т. and Tsysnetska А. 2022. The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. Actual Problems of Medicine and Pharmacy. 3, 1 (May 2022), 1–10. DOI:https://doi.org/10.52914/apmp.v3i1.42.